Health Canada Approves GlucaGen(R) For Treatment Of Severe Hypoglycemia In Diabetes Patients
Links shared publicly online about this topic.
- 1,723total visits
Health Canada Approves GlucaGen(R) For Treatment Of Severe Hypoglycemia In Diabetes Patients
Paladin labs inc. (tsx:plb), a leading canadian specialty pharmaceutical company, announced today that the biologics and genetic therapies directorate of health canada has approved glucagen® (
View full resource at medicalnewstoday.com
Tags: Genetic, Diabetes, Low Blood Sugar, Pharma
Most Recently Shared on September 25, 2009 at 1:13 pm By:
Health Canada Approves GlucaGen(R) For Treatment Of Severe Hypoglycemia In Diabetes Patients: Paladin Labs Inc... http://bit.ly/7sTHl
Advertisement
